ACB
Aristotle Capital Boston’s Cross Country Healthcare CCRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.1M | Sell |
697,102
-38,639
| -5% | -$504K | 0.46% | 80 |
|
|
2025
Q1 | $11M | Sell |
735,741
-124,954
| -15% | -$1.86M | 0.55% | 74 |
|
|
2024
Q4 | $15.6M | Sell |
860,695
-96,730
| -10% | -$1.76M | 0.58% | 70 |
|
|
2024
Q3 | $12.9M | Buy |
957,425
+49,864
| +5% | +$670K | 0.43% | 83 |
|
|
2024
Q2 | $12.6M | Sell |
907,561
-14,202
| -2% | -$197K | 0.42% | 83 |
|
|
2024
Q1 | $17.3M | Buy |
921,763
+7,969
| +0.9% | +$149K | 0.52% | 74 |
|
|
2023
Q4 | $20.7M | Buy |
913,794
+23,391
| +3% | +$530K | 0.63% | 72 |
|
|
2023
Q3 | $22.1M | Buy |
890,403
+2,831
| +0.3% | +$70.2K | 0.71% | 58 |
|
|
2023
Q2 | $24.9M | Buy |
887,572
+11,481
| +1% | +$322K | 0.75% | 54 |
|
|
2023
Q1 | $19.6M | Sell |
876,091
-216,424
| -20% | -$4.83M | 0.6% | 69 |
|
|
2022
Q4 | $29M | Sell |
1,092,515
-472,194
| -30% | -$12.5M | 0.92% | 46 |
|
|
2022
Q3 | $44.4M | Sell |
1,564,709
-73,903
| -5% | -$2.1M | 1.5% | 9 |
|
|
2022
Q2 | $34.1M | Buy |
1,638,612
+86,397
| +6% | +$1.8M | 1.02% | 34 |
|
|
2022
Q1 | $33.6M | Sell |
1,552,215
-57,156
| -4% | -$1.24M | 0.85% | 49 |
|
|
2021
Q4 | $44.7M | Sell |
1,609,371
-14,175
| -0.9% | -$393K | 1.05% | 33 |
|
|
2021
Q3 | $34.5M | Sell |
1,623,546
-452,840
| -22% | -$9.62M | 0.81% | 53 |
|
|
2021
Q2 | $34.3M | Sell |
2,076,386
-411,839
| -17% | -$6.8M | 0.78% | 50 |
|
|
2021
Q1 | $31.1M | Buy |
2,488,225
+14,854
| +0.6% | +$186K | 0.69% | 60 |
|
|
2020
Q4 | $21.9M | Sell |
2,473,371
-65,444
| -3% | -$580K | 0.52% | 86 |
|
|
2020
Q3 | $16.5M | Sell |
2,538,815
-374,422
| -13% | -$2.43M | 0.48% | 86 |
|
|
2020
Q2 | $17.9M | Buy |
2,913,237
+293,248
| +11% | +$1.81M | 0.55% | 73 |
|
|
2020
Q1 | $17.7M | Sell |
2,619,989
-76,382
| -3% | -$515K | 0.76% | 52 |
|
|
2019
Q4 | $31.3M | Buy |
2,696,371
+123,249
| +5% | +$1.43M | 0.86% | 48 |
|
|
2019
Q3 | $26.5M | Buy |
2,573,122
+257,053
| +11% | +$2.65M | 0.78% | 52 |
|
|
2019
Q2 | $21.7M | Buy |
2,316,069
+46,349
| +2% | +$435K | 0.68% | 64 |
|
|
2019
Q1 | $16M | Buy |
2,269,720
+1,142,815
| +101% | +$8.03M | 0.53% | 84 |
|
|
2018
Q4 | $8.26M | Buy |
1,126,905
+125,669
| +13% | +$921K | 0.68% | 68 |
|
|
2018
Q3 | $8.74M | Buy |
1,001,236
+48,182
| +5% | +$421K | 0.64% | 75 |
|
|
2018
Q2 | $10.7M | Sell |
953,054
-547,849
| -37% | -$6.16M | 0.85% | 62 |
|
|
2018
Q1 | $16.7M | Buy |
1,500,903
+535,936
| +56% | +$5.95M | 0.78% | 53 |
|
|
2017
Q4 | $12.3M | Buy |
964,967
+202,767
| +27% | +$2.59M | 0.9% | 44 |
|
|
2017
Q3 | $10.8M | Buy |
762,200
+172,018
| +29% | +$2.45M | 0.97% | 39 |
|
|
2017
Q2 | $7.62M | Buy |
590,182
+114,395
| +24% | +$1.48M | 0.85% | 55 |
|
|
2017
Q1 | $6.83M | Buy |
475,787
+42,656
| +10% | +$613K | 0.91% | 43 |
|
|
2016
Q4 | $6.76M | Buy |
433,131
+42,023
| +11% | +$656K | 0.93% | 43 |
|
|
2016
Q3 | $4.61M | Buy |
391,108
+43,914
| +13% | +$517K | 0.82% | 57 |
|
|
2016
Q2 | $4.83M | Buy |
347,194
+12,438
| +4% | +$173K | 0.94% | 45 |
|
|
2016
Q1 | $3.89M | Buy |
334,756
+8,014
| +2% | +$93.2K | 0.78% | 64 |
|
|
2015
Q4 | $5.36M | Buy |
326,742
+76,945
| +31% | +$1.26M | 1.09% | 33 |
|
|
2015
Q3 | $3.4M | Buy |
249,797
+10,715
| +4% | +$146K | 0.83% | 55 |
|
|
2015
Q2 | $3.03M | Buy |
239,082
+63,363
| +36% | +$804K | 0.69% | 72 |
|
|
2015
Q1 | $2.08M | Buy |
175,719
+57,445
| +49% | +$681K | 0.65% | 78 |
|
|
2014
Q4 | $1.48M | Buy |
+118,274
| New | +$1.48M | 0.74% | 65 |
|